a physician a building location a clinical trial a department
menu
BCM - Baylor College of Medicine

Giving life to possible

Clinical Trials

A Current Practice Study Of Rituxan In Patients Receiving BEAM Chemotherapy And Autologous Blood Stem Cell Transplantation For High Risk Lymphoma And Hodgkin's Disease (H-11892)

H-11892: A Current Practice Study Of Rituxan In Patients Receiving BEAM Chemotherapy And Autologous Blood Stem Cell Transplantation For High Risk Lymphoma And Hodgkin's Disease:This study uses a monoclonal antibody and high dose chemotherapy combined with autologous stem cell transplantation.